Last reviewed · How we verify

NCT05355558

A Novel Functional Imaging Technique With FLT-PET/MRI For Staging, Response Assessment and Radiation Treatment Planning in Cervix Cancer

Status unknown NA Last updated 2 May 2022
What this trial tests

NA trial testing [18F]FLT-PET/MRI body scan in Image, Body in 15 participants. Status unknown.

Timeline
14 May 2019
Primary endpoint
31 December 2022
31 December 2022

Quick facts

Lead sponsorNational Cancer Centre, Singapore
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment15
Start date14 May 2019
Primary completion31 December 2022
Estimated completion31 December 2022
Sites1 location across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

National Cancer Centre, Singapore

Who can join

Adults 21 to 99, any sex, with Image, Body or Cervix Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot study aims to monitor early tumour response based on \[18F\]FLT-PET/MRI scans and to determine the feasibility of personalised radiotherapy to spare active bone marrow areas identified by \[18F\]FLT-PET/MRI. Bone marrow within the pelvis will be outlined by employing 18FLT PET to identify active BM within bony structures. Subsequently, treatment plans with various conformal radiotherapy techniques will be generated with different optimization approaches toward bone marrow while ensuring adequate tumor coverage. Dosimetric comparison amongst plans will be carried out.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Current Update on PET/MRI in Gynecological Malignancies-A Review of the Literature.
    Virarkar M, Vulasala SS, Calimano-Ramirez L, Singh A, et al · · 2023 · cited 5× · PMID 36661732 · DOI 10.3390/curroncol30010083

Verify or expand the search:

Other recruiting trials for Image, Body

Currently open trials in the same condition.

Other National Cancer Centre, Singapore trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05355558.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing